| Literature DB >> 22486623 |
Pubudu M Peiris1, Lisa Bauer, Randall Toy, Emily Tran, Jenna Pansky, Elizabeth Doolittle, Erik Schmidt, Elliott Hayden, Aaron Mayer, Ruth A Keri, Mark A Griswold, Efstathios Karathanasis.
Abstract
While nanoparticles maximize the amount of chemotherapeutic drug in tumors relative to normal tissues, nanoparticle-based drugs are not accessible to the majority of cancer cells because nanoparticles display patchy, near-perivascular accumulation in tumors. To overcome the limitations of current drugs in their molecular or nanoparticle form, we developed a nanoparticle based on multicomponent nanochains to deliver drug to the majority of cancer cells throughout a tumor while reducing off-target delivery. The nanoparticle is composed of three magnetic nanospheres and one doxorubicin-loaded liposome assembled in a 100 nm long chain. These nanoparticles display prolonged blood circulation and significant intratumoral deposition in tumor models in rodents. Furthermore, the magnetic particles of the chains serve as a mechanical transducer to transfer radio frequency energy to the drug-loaded liposome. The defects on the liposomal walls trigger the release of free drug capable of spreading throughout the entire tumor, which results in a widespread anticancer effect.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22486623 PMCID: PMC3358486 DOI: 10.1021/nn300652p
Source DB: PubMed Journal: ACS Nano ISSN: 1936-0851 Impact factor: 15.881